Nature, Published online: 12 November 2025; doi:10.1038/s41586-025-09741-1

CRISPR–Cas9-based genome-wide screening shows that SIGLEC12 mediates plasma membrane rupture in cells undergoing necroptosis, possibly through a human-specific mechanism, indicating its potential as a therapeutic target.


From Nature via this RSS feed